CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19

NCT04898062 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped sufficient recruitment of study patients based on the existing inclusion and exclusion criteria is not possible within a reasonable period of time

Conditions

Interventions

Sponsor

Pentracor GmbH